Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Clinical Trial

Published on 09 May 2025

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

in Multiple Sclerosis and Neuroimmunology

Mahsa Hosseini
Soheila Shamsikhani
Ali Jadidi
Fatemeh Rafiei

Frontiers in Neurology

doi 10.3389/fneur.2025.1521112

417 views

Original Research

Published on 09 May 2025

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

in Multiple Sclerosis and Neuroimmunology

Shan Qiao
Jia Wang
Shan-chao Zhang
Ai-hua Wang
Hai-yun Li
Tao Xin

Frontiers in Neurology

doi 10.3389/fneur.2025.1568274

478 views

Correction

Published on 08 May 2025

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

in Multiple Sclerosis and Neuroimmunology

Domenico A. Restivo
Angelo Quartarone
Antongiulio Bruschetta
Angelo Alito
Demetrio Milardi
Rosario Marchese-Ragona
Ennio Iezzi
Sheila Peter
Diego Centonze
Mario Stampanoni Bassi

Frontiers in Neurology

doi 10.3389/fneur.2025.1613012

450 views

Original Research

Published on 07 May 2025

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

in Multiple Sclerosis and Neuroimmunology

Mohammadali Arami
Rezafarhad Manteghifasaei
Mohammad Karimi
Puya Zandi
Mobina Javadi

Frontiers in Neurology

doi 10.3389/fneur.2025.1565912

604 views

Original Research

Accepted on 06 May 2025

Progression independent of relapsing biology in multiple sclerosis: a real-word study

in Multiple Sclerosis and Neuroimmunology

Heather Yong
Carlos Rodrigo Camara-Lemarroy

Frontiers in Neurology

doi 10.3389/fneur.2025.1595929

Original Research

Accepted on 05 May 2025

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

in Multiple Sclerosis and Neuroimmunology

Qiqi Peng
Xiaoping Yao
Sheng Chen
Xiaofeng Li
Feifei Lin
Zhangyu Zou

Frontiers in Neurology

doi 10.3389/fneur.2025.1560483

Original Research

Published on 30 Apr 2025

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Eman M. Khedr
Gellan K. Ahmed
Shady Safwat Hassan
Mohamed Nageh Foly
Motez Mahmoud Attia
Ahmed A. Karim
Nourelhoda A. Haridy

Frontiers in Neurology

doi 10.3389/fneur.2025.1563041

347 views

Original Research

Accepted on 29 Apr 2025

Long-term Outcomes in Leucine-Rich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis and Associated Biomarkers of Inflammation, Neuronal and Glial Injury

in Multiple Sclerosis and Neuroimmunology

Tyler L Borko
Phillip Winters
Kelli M Money
Stefan Sillau
Sadie Eggmann
Sean Selva
Alanna Richie
Ryan Kammeyer
Gregory P Owens
Jeffrey L Bennett

Frontiers in Neurology

doi 10.3389/fneur.2025.1583892

107 views

Original Research

Published on 29 Apr 2025

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

in Multiple Sclerosis and Neuroimmunology

Miguel Ángel Robles-Sánchez
Paloma Amil-Bujan
Cristina Bosch-Farré
Clàudia Coll-Martínez
María Jesús Arévalo
Elisenda Anglada-Clofent
Rebeca Menéndez-Díaz
Montserrat Aroca-Alsina
Miguel Merchan-Ruiz
Santiago Pérez-Hoyos

Frontiers in Neurology

doi 10.3389/fneur.2025.1581038

719 views

Original Research

Published on 28 Apr 2025

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

in Multiple Sclerosis and Neuroimmunology

Jing Zhou
Xiaolin Yang
Xinyi Wang
Bin Li
Yun Xu
Haoran Zhang
Yinxin Zhu
Xiaoming Wang
Jinzhou Feng

Frontiers in Neurology

doi 10.3389/fneur.2025.1559118

710 views

Original Research

Published on 28 Apr 2025

Resolution of anti-GAD-associated autoimmune encephalitis in patients treated with efgartigimod

in Multiple Sclerosis and Neuroimmunology

Min Chen
Zhuajin Bi
Wenzhong Kang
Ruihan Liu
Liu Hongbo
Yan Jiang
Qun Wang

Frontiers in Neurology

doi 10.3389/fneur.2025.1550023

486 views

Study Protocol

Accepted on 25 Apr 2025

RECLAIM – A retrospective, multicentre observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jelle Praet
Lina Anderhalten
Giancarlo Comi
Dana Horakova
Tjalf Ziemssen
Patrick Vermersch
Carsten Lukas
Koen Van Leemput
Marjan Steppe
Noemí Manero

Frontiers in Neurology

doi 10.3389/fneur.2025.1557947

157 views

Original Research

Accepted on 25 Apr 2025

CONFIDENCE treatment success: Long-term real-world effectiveness and safety of ocrelizumab in Germany

in Multiple Sclerosis and Neuroimmunology

Mathias Buttmann
Martin S Weber
Sven G Meuth
Sandra Blümich
Stefanie Hieke-Schulz
Petra Dirks
Julius C Eggebrecht
Tjalf Ziemssen

Frontiers in Neurology

doi 10.3389/fneur.2025.1564327

191 views

Original Research

Published on 16 Apr 2025

Raman liquid biopsy: a new approach to the multiple sclerosis diagnostics

in Multiple Sclerosis and Neuroimmunology

Anna Neupokoeva
Ivan Bratchenko
Lyudmila Bratchenko
Elena Khivintseva
Igor Shirolapov
Natalia Shusharina
Matvei Khoimov
Valery Zakharov
Alexander Zakharov

Frontiers in Neurology

doi 10.3389/fneur.2025.1516712

586 views

Original Research

Published on 15 Apr 2025

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

in Multiple Sclerosis and Neuroimmunology

Ann-Sophie Stratil
Steffeni Papukchieva
Nils-Henning Neß
Inge Wolf
Antonios Bayas
Peter Flachenecker
Benjamin Friedrich

Frontiers in Neurology

doi 10.3389/fneur.2025.1561810

1,048 views

Case Report

Published on 10 Apr 2025

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

in Multiple Sclerosis and Neuroimmunology

Rui-Ting Liu
Yu-Kun Guo
Xia Du
Heng Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1559872

1,078 views